Učitavanje...
Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
More than twenty-five years of research and pre-clinical validation have defined EphA2 receptor tyrosine kinase as a promising molecular target for clinical translation in cancer treatment. Molecular, genetic, biochemical, and pharmacological targeting strategies have been extensively tested in vitr...
Spremljeno u:
| Izdano u: | Oncogene |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035212/ https://ncbi.nlm.nih.gov/pubmed/33686241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-021-01714-8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|